ESR1 and breast cancer: For example, increased cyclin D1 mRNA and amplification of CCND1 in ER+ breast cancers strongly correlated with increased risk of relapse, local recurrence, metastasis, and death [30,31,48], and ER- patients with cyclin D1 overexpression display shorter overall survival [33].